*mymedicalexpo

n-IBS®

Product catalog summary

Product Overview
n-IBS® is an injectable, resorbable hydroxyapatite paste designed for bone defects. It is non-hardening and delivered in a Luer-lock syringe, ready for use without preparation. The paste remains soft to adapt to irregular bone cavities, supporting early blood clot formation and vascularization.

Applications

Spine surgery (e.g., cages)
Trauma and orthopedic procedures (e.g., bone marrow lesions, cysts)
Dental/maxillofacial surgeries (e.g., sinus lift, ridge augmentation)

Technical Specifications

Type: Injectable bone substitute (non-hardening)
Composition: Hydroxyapatite nanoparticles (<100 nm)
Formulation: Monophasic aqueous dispersion
Final Form: Soft gel-like paste
Delivery: Pre-filled sterile syringe (Luer-lock)
Biological Action: Promotes early vascularization
Resorption Time: Approximately 6 months
Radiopacity: Yes
Color: White
Cellular Integration: Supports osteoconduction and cellular migration
Porosity: Nanostructure enhances surface area
Clinical Performance: 94–100% consolidation in 12–18 months

Product Variants

nIBS011: 1cc - 1 syringe
nIBS031: 3cc - 1 syringe
nIBS051: 5cc - 1 syringe
nIBS052: 10cc - 2 syringes of 5cc each

Intended Use
n-IBS® is intended for filling non-load-bearing bone voids that are not essential to the mechanical stability of the skeleton.

Manufacturer Information
Bioceramed S.A, located in AvePark – Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal. Contact: +351 253 573 460, [email protected], www.bioceramed.com

Catalog excerpts

Bone Substitutes | Orthobiologics n-IBS® Injectable, Resorbable Hydroxyapatite Paste Innovating Future Life.

Open the catalog to page 1

n-IBS® Injectable, non-hardening hydroxyapatite for bone defects. Spine surgery (e.g. cages) Dental/maxillofacial (e.g. sinus lift, ridge aug) Trauma and ortho (e.g. BMLs, cysts) Luer-lock syringe Secure, ready-to-use delivery. No preparation needed. Paste consistency Remains soft to adapt to irregular bone cavities. Supports early blood clot and vascularization. Innovating Future Life.

Open the catalog to page 2

Product Type Injectable bone substitute Resorption Time ~6 months average Nanostructure enhances surface area Delivery Pre-filled sterile syringe Porosity Biological Promotes early Clinical 94-100% consolidation Action vascularization Performance in 12-18 months n-IBS® is indicated for filling non-load-bearing bone voids not essential to the mechanical stability of the skeleton. Filling bone voids in spinal cages Sinus lift procedures Alveolar ridge augmentation Post-cystectomy bone defects Bone marrow lesions (knee, hip) Bone graft extender n-IBS® Injectable Bone Substitute nIBS011 1cc - 1 syringe...

Open the catalog to page 3

Engineering Regenerative Solutions for Bone Repair. Bioceramed S.A AvePark – Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal +351 253 573 460 [email protected] www.bioceramed.com Innovating Future Life

Open the catalog to page 4

All Bioceramed catalogs and technical brochures

Archived catalogs

NEOCEMENT INJECT P
2 Pages
n-IBS
2 Pages